Ardsley Advisory Partners’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
Other funds holding BSX
ATO
RG
YIH
BPC
FFM
Ardsley Advisory Partners's BSX Position: Q2 2026 in Review
Ardsley Advisory Partners sold out of Boston Scientific (BSX) in Q2 2026, closing a stake of 150,000 shares — an estimated $9.41M sold.
Ardsley Advisory Partners first reported a position in BSX in Q4 2013 and held it in 21 quarters. The position peaked at $9.41M in Q1 2026. 425 funds tracked by Wall St. Rank hold BSX as of Q2 2026.
- Ardsley Advisory Partners reported no remaining Boston Scientific position as of Q2 2026 after selling out during the quarter.
- Ardsley Advisory Partners sold 150,000 Boston Scientific shares in Q2 2026, an estimated $9.41M.
- Ardsley Advisory Partners first reported a position in Boston Scientific in Q4 2013 and held it in 21 quarters.
- Ardsley Advisory Partners's Boston Scientific position peaked at $9.41M in Q1 2026.
- 425 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.
Based on Ardsley Advisory Partners's 13F filing for Q2 2026, filed 13 Jul 2026.